ASPEN AEROGELS INC (ASPN) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-05-14

Key Insights

Director Steven R. Mitchell received 10,370 restricted stock units (RSUs) as part of annual non-employee director compensation, vesting in May 2027 or prior to the 2027 annual meeting, indicating continued board engagement.
Mitchell also received 8,706 stock options with a $5.40 exercise price and 10-year expiration, representing confidence in long-term company value at current market levels.
Total beneficial ownership increased to 156,898 shares following the transaction, with the RSU grant constituting a routine component of director compensation rather than a discretionary insider buy signal.
The transaction is non-discretionary equity compensation awarded pursuant to the company's director compensation policy, providing minimal insight into insider sentiment regarding stock valuation or near-term prospects.

Want the newest filings?

This analysis covers the filing from 2026-05-14. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-05-14

Director James E. Sweetnam received annual equity compensation consisting of 10,370 RSUs and 8,706 stock options, a standard director compensation arrangement indicating normal board governance practices.
RSUs and options vest on May 13, 2027, or prior to the 2027 annual stockholder meeting, creating a retention incentive aligned with shareholder interests through equity-based compensation.
Sweetnam's total beneficial ownership increased to 36,321 shares following the grant, demonstrating modest accumulated equity stake as a board member rather than significant insider accumulation.
The $5.40 exercise price on granted options reflects the compensation grant date valuation and represents the current or recent market price, indicating standard option grant practices.

Filed: 2026-05-14

Director William P. Noglows acquired 10,370 restricted stock units (RSUs) as part of annual non-employee director compensation, with vesting scheduled for May 2027 or prior to the 2027 annual meeting, indicating standard equity grant practices.
Noglows also received 8,706 stock options at $5.40 exercise price as part of director compensation, vesting on the same schedule, demonstrating the company's use of equity incentives for board retention.
Following the transaction, Noglows beneficially owns 99,357 common shares directly plus an additional 20,000 shares held indirectly through two trusts for his children, reflecting a substantial accumulated stake in the company.
The transactions were executed at $0 price for RSUs and options, representing standard equity grants rather than open market purchases, which carries minimal insider confidence signal regarding stock valuation.

Filed: 2026-05-14

Director Kathleen Kool received annual equity compensation consisting of 10,370 RSUs and 8,706 stock options, representing standard non-employee director grants rather than discretionary awards, indicating regular compensation practices.
RSUs and options both vest on May 13, 2027 or the day prior to the 2027 annual shareholder meeting, with options exercisable at $5.40 per share, suggesting the company stock was trading near that level on the grant date.
Following this transaction, Kool's total beneficial ownership is 34,323 shares (23,953 shares plus 10,370 RSUs), demonstrating modest director-level ownership stake in ASPEN Aerogels.
The $0 price notation for RSUs and the option exercise price of $5.40 reflect standard SEC reporting conventions for equity grants; this is a routine annual compensation issuance with no unusual terms or conditions.

Filed: 2026-05-14

Director Cari Robinson received annual equity compensation of 10,370 RSUs and 8,706 stock options on 05/13/2026, representing routine non-employee director compensation rather than insider buying activity.
Robinson's total beneficial ownership increased to 22,616 shares following the grant, with RSUs vesting on the earlier of May 13, 2027 or the day prior to the 2027 annual meeting, indicating standard director retention practices.
The $5.40 exercise price on the granted stock options reflects the compensation grant date valuation and does not indicate any market timing or insider confidence signals regarding future stock performance.
As a non-employee director, Robinson's holdings and compensation structure are governed by the company's Non-Employee Director Compensation Policy, suggesting governance compliance rather than material insider activity to monitor.

Filed: 2026-03-10

The reporting person, Grant Douglas Thoele, who is the Chief Financial Officer and Treasurer of Aspen Aerogels Inc., disposed of 590 shares of the company's common stock to satisfy minimum statutory tax withholding requirements on the vesting of his restricted stock units (RSUs).
Following the reported transaction, the reporting person beneficially owns a total of 77,732 shares, consisting of 10,111 shares of common stock and 67,621 RSUs.
The transaction appears to be a routine practice of an insider selling shares to cover tax obligations, which is a common occurrence for executives holding equity-based compensation.

Filed: 2026-03-10

Corby C. Whitaker, the Chief Commercial Officer of Aspen Aerogels Inc., disposed of 1,924 shares of common stock through a share withholding transaction to satisfy minimum statutory tax withholding requirements on the vesting of restricted stock units (RSUs).
Whitaker continues to beneficially own 205,315 shares of Aspen Aerogels' common stock, including 77,145 RSUs, indicating he maintains a significant ownership stake in the company.
The reported transaction is a routine, non-discretionary event related to the vesting of Whitaker's equity compensation and does not suggest any broader changes in his investment position or outlook on the company.

Filed: 2026-03-10

The reporting person, Donald R. Young, is the President and CEO of Aspen Aerogels Inc., indicating his significant leadership role in the company.
Donald R. Young disposed of 4,275 shares of Aspen Aerogels common stock, likely to satisfy minimum statutory tax withholding requirements on the vesting of his Restricted Stock Units (RSUs).
After the reported transaction, Donald R. Young continues to beneficially own a substantial number of shares (637,834) and RSUs (199,485), suggesting his continued commitment and alignment with the company's long-term success.

Filed: 2026-03-10

Gregg Landes, the Chief Operating Officer of Aspen Aerogels Inc., disposed of 1,924 shares of the company's common stock through a share withholding transaction to satisfy minimum tax withholding requirements.
Landes still holds a significant stake of 102,931 shares in the company, indicating his continued commitment to Aspen Aerogels.
The transaction was routine and likely part of a pre-planned arrangement to manage tax obligations related to the vesting of restricted stock units (RSUs).

Filed: 2026-03-06

The reporting person, Grant Douglas Thoele, was granted 55,298 restricted stock units (RSUs) on March 4, 2026, which will vest over the next 3 years.
Thoele also exercised 74,893 stock options with an exercise price of $3.35 on the same date, further increasing his stake in the company.
Thoele sold 2,368 shares on March 5, 2026 to cover the minimum statutory tax withholding requirements on the vesting of the RSUs.

Filed: 2026-03-06

Donald R. Young, the President and CEO of Aspen Aerogels, Inc., has been granted 156,716 restricted stock units (RSUs) that will vest over the next 3 years, indicating the company's commitment to retaining its top leadership.
Young also exercised 212,249 stock options with an exercise price of $3.35, suggesting his confidence in the company's long-term growth potential.
The company withheld 8,618 shares from Young to cover minimum statutory tax withholding requirements on the vesting of his RSUs, a common practice for equity-based compensation.

Filed: 2026-03-06

Gregg Landes, the SVP of Operations and Strategic Development, acquired 57,462 restricted stock units (RSUs) on March 4, 2026, which will vest over the next 3 years.
Landes also exercised 77,824 stock options on the same date, with a strike price of $3.35 and an expiration date of March 4, 2036.
Landes sold 3,814 shares to cover the minimum statutory tax withholding requirements on the vesting of the RSUs, indicating a focus on long-term ownership.

Filed: 2026-03-06

Insider Glenn E. Deegan, who is the Chief Accounting Officer, General Counsel, and Corporate Secretary of Aspen Aerogels Inc, acquired 55,503 shares of the company's common stock through restricted stock units that vest over the next 3 years.
Deegan also received 75,171 stock options with an exercise price of $3.35 that vest over the next 3 years, indicating his commitment to the company's long-term success.
The insider buying activity suggests Deegan has a positive outlook on Aspen Aerogels' future performance and is aligning his interests with those of shareholders.

Filed: 2026-03-06

Corby C. Whitaker, the SVP of Sales and Marketing at Aspen Aerogels, has acquired 57,462 shares of the company's common stock, indicating his confidence in the company's future prospects.
Whitaker also received stock options to purchase 77,824 shares of common stock, further aligning his interests with those of the company and its shareholders.
The company's share price of $3.27 at the time of the reported transactions suggests a reasonable valuation, as Whitaker's transactions were executed at the current market price.

Filed: 2026-03-06

Daniel Santhosh P, the Chief Accounting Officer of Aspen Aerogels Inc (ASPN), disposed of 986 shares of common stock through a stock withholding transaction to satisfy minimum tax withholding requirements on the vesting of restricted stock units (RSUs).
Santhosh P still holds a total of 15,330 shares of ASPN stock, consisting of 5,593 direct shares and 9,737 RSUs, indicating his continued investment in the company.
The stock transaction appears to be a routine event related to the vesting of employee equity compensation, rather than a significant change in Santhosh P's ownership position.

Other reports for ASPEN AEROGELS INC

Quarterly Report Current Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.